These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 38726624)
1. Retrospective study of qualitative assessment in detecting synchronous and metachronous malignancies in adult cancer patients by 18 F-FDG PET/CT. Lau JHY; Ng KK; Wong WC; Ng KS; Chu KS; Au-Yong TK; Kung BT Nucl Med Commun; 2024 Aug; 45(8):710-717. PubMed ID: 38726624 [TBL] [Abstract][Full Text] [Related]
2. Impact of FDG PET/CT on detection of synchronous and metachronous malignancies and clinical management in patients with multiple primary cancers. Ilcheva M; Nikolova P; Hadzhiyska V; Mladenov K Neoplasma; 2022 Jul; 69(4):948-956. PubMed ID: 35471980 [TBL] [Abstract][Full Text] [Related]
3. Multiple primary malignant tumors of upper gastrointestinal tract: a novel role of 18F-FDG PET/CT. Sun L; Wan Y; Lin Q; Sun YH; Zhao L; Luo ZM; Wu H World J Gastroenterol; 2010 Aug; 16(31):3964-9. PubMed ID: 20712059 [TBL] [Abstract][Full Text] [Related]
5. Incidentally found parotid gland lesion in Jung JH; Lee YS; Jung YH; Choi SH; Nam SY; Cho HJ; Kwon M BMC Surg; 2024 Apr; 24(1):124. PubMed ID: 38658868 [TBL] [Abstract][Full Text] [Related]
6. Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT. Strobel K; Haerle SK; Stoeckli SJ; Schrank M; Soyka JD; Veit-Haibach P; Hany TF Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):919-27. PubMed ID: 19205699 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of incidental [18 F]FDG uptake in the gastrointestinal tract on PET/CT imaging: a retrospective cohort study. Shmidt E; Nehra V; Lowe V; Oxentenko AS BMC Gastroenterol; 2016 Oct; 16(1):125. PubMed ID: 27716085 [TBL] [Abstract][Full Text] [Related]
8. Chest radiography or chest CT plus head and neck CT versus Kim Y; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY Oral Oncol; 2019 Jan; 88():109-114. PubMed ID: 30616780 [TBL] [Abstract][Full Text] [Related]
9. Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study. Quartuccio N; Evangelista L; Alongi P; Caobelli F; Altini C; Cistaro A; Lambertini A; Schiorlin I; Popescu CE; Linguanti F; Laudicella R; Scalorbi F; Di Pierro G; Asabella AN; Cuppari L; Margotti S; Lima GM; Scalisi S; Pacella S; Kokomani A; Ciaccio A; Sturiale L; Vento A; Cardile D; Baldari S; Panareo S; Fanti S; Rubini G; Schillaci O; Chiaravalloti A; Nucl Med Commun; 2019 Aug; 40(8):808-814. PubMed ID: 31136534 [TBL] [Abstract][Full Text] [Related]
10. (18)F-FDG PET-detected synchronous primary neoplasms in the staging of esophageal cancer: incidence, cost, and impact on management. Malik V; Johnston C; Donohoe C; Claxton Z; Lucey J; Ravi N; Reynolds JV Clin Nucl Med; 2012 Dec; 37(12):1152-8. PubMed ID: 23154472 [TBL] [Abstract][Full Text] [Related]
11. The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma. Liu Y Nucl Med Commun; 2017 Apr; 38(4):319-324. PubMed ID: 28225435 [TBL] [Abstract][Full Text] [Related]
12. Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer. Suzuki H; Hasegawa Y; Terada A; Ogawa T; Hyodo I; Suzuki M; Nakashima T; Tamaki T; Nishio M Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1191-5. PubMed ID: 19015450 [TBL] [Abstract][Full Text] [Related]
13. Clinical and prognostic value of 18F-FDG-PET/CT in restaging of pancreatic cancer. Albano D; Familiari D; Gentile R; Scalisi S; Midiri F; Messina M; Spada M; Fornito MC; Galia M; Midiri M; Alongi P Nucl Med Commun; 2018 Aug; 39(8):741-746. PubMed ID: 29782393 [TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of 18F-FDG PET/CT for detecting synchronous advanced colorectal neoplasia in patients with gastric cancer. Choi BW; Kim HW; Won KS; Song BI; Cho KB; Bae SU Medicine (Baltimore); 2016 Sep; 95(36):e4741. PubMed ID: 27603371 [TBL] [Abstract][Full Text] [Related]
16. Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma. Hou G; Zhao D; Jiang Y; Zhu Z; Huo L; Li F; Cheng W Cancer Imaging; 2021 Feb; 21(1):25. PubMed ID: 33632314 [TBL] [Abstract][Full Text] [Related]
17. (18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer. Ulaner GA; Castillo R; Goldman DA; Wills J; Riedl CC; Pinker-Domenig K; Jochelson MS; Gönen M Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1937-44. PubMed ID: 27129866 [TBL] [Abstract][Full Text] [Related]
18. DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile cancer. Jakobsen JK; Frahm Nielsen T; Ipsen P; Albrecht-Beste E; Cardoso Costa J; Alslev L; Predbjørn Krarup K; Grønkaer Toft B; Høyer S; Bouchelouche K; Bjerggaard Jensen J BJU Int; 2021 Feb; 127(2):254-262. PubMed ID: 33448605 [TBL] [Abstract][Full Text] [Related]
19. Frequency and clinical implications of incidental new primary cancers detected on true whole-body 18F-FDG PET/CT studies. Sebro R; Aparici CM; Pampaloni MH Nucl Med Commun; 2013 Apr; 34(4):333-9. PubMed ID: 23407371 [TBL] [Abstract][Full Text] [Related]
20. The clinical significance of 18F-FDG-PET/CT in early detection of second primary malignancy in cancer patients. Xu H; Zhang M; Zhai G; Li B J Cancer Res Clin Oncol; 2010 Aug; 136(8):1125-34. PubMed ID: 20091320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]